Difference between revisions of "Okroj M, et al. Cancer Treat. Rev. (2013) cited as Ref 717 in DOI: 10.1038/s41392-020-0110-5 (Q9980)"
Jump to navigation
Jump to search
(Added link to [sliswiki]: Okroj M, et al. Cancer Treat. Rev. (2013) cited as Ref 717 in DOI: 10.1038/s41392-020-0110-5, #quickstatements; #temporary_batch_1589988087154) |
(Created claim: Page(s) (P105): 632-639, #quickstatements; #temporary_batch_1590074839150) |
||||||||||||||
| (9 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / First Author string | |||||||||||||||
| + | Okroj M | ||||||||||||||
| Property / First Author string: Okroj M / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Second Author string | |||||||||||||||
| + | Osterborg A | ||||||||||||||
| Property / Second Author string: Osterborg A / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Third Author string | |||||||||||||||
| + | Blom AM | ||||||||||||||
| Property / Third Author string: Blom AM / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1016/j.ctrv.2012.10.008 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 23219151 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2013
| ||||||||||||||
| Property / Publication Date: 2013 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Cancer Treat. Rev. | ||||||||||||||
| Property / Published In Name String: Cancer Treat. Rev. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 39 | ||||||||||||||
| Property / Volume: 39 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies (English) | ||||||||||||||
| Property / title: Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 632-639 | ||||||||||||||
| Property / Page(s): 632-639 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 15:50, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Okroj M, et al. Cancer Treat. Rev. (2013) cited as Ref 717 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Okroj M
0 references
Osterborg A
0 references
Blom AM
0 references
2013
0 references
Cancer Treat. Rev.
0 references
39
0 references
Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignancies (English)
0 references
632-639
0 references
